One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-147323
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 25 |
Affiliation: Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, German Cancer Research Center, University of Cologne, Essen University Hospital, SLK-Kliniken Heilbronn, Universitätsklinikum Knappschaftskrankenhaus Bochum, Johannes Gutenberg University Mainz, Klinikum Chemnitz, Asklepios Klinik Altona, Philipps University of Marburg, Kliniken Maria Hilf, University Medical Center Hamburg-Eppendorf, Universität Hamburg, Praxis für Hämatologie und Onkologie, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Klinikum Mutterhaus der Borromäerinnen, Kliniken Essen-Mitte, Heinrich Heine University Düsseldorf, Düsseldorf University Hospital, University of Tübingen, University Hospital Frankfurt, Goethe University Frankfurt, Westpfalz Klinikum
Elotuzumab in Combination with Lenalidomide, Bortezomib, Dexamethasone and Autologous Transplantation for Newly-Diagnosed Multiple Myeloma: Results from the Randomized Phase III GMMG-HD6 Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
